- Products
- Workflow Benefits
- Science & Education
Stay in Front with Gadovist®
Behind Every Dose of Gadovist® is Bayer
At Bayer, we believe that there is only one way to go: Forward. We share a joint vision with you to improve patient’s lives from diagnosis to care, because everyone deserves clear answers about their health.
Expertise
Gadovist® : Celebrating the Jubilee with 120+ Million Administrations
Gadovist® has just reached a significant milestone, and we could not be more proud. It was also recently explored in an extensive review. The results are in – and Gadovist® has maintained clinical safety and efficacy across any indications and populations, including neonates, while continuing to push expectations through notable studies such as GadaCAD, DENSE, and LEADER-75.*
Celebrate this jubilee by seeing how Gadovist® can help you stay in front.
* Check local guidelines.
Expertise
An Established History in Healthcare
With over 125 years of healthcare experience, we understand the powerful role that medical imaging plays in selecting appropriate treatment options and facilitating proper follow-up care.
With over 120 million procedures in over 100 countries, you can rely on Gadovist®, our second generation GBCA.
Bayer is committed to bringing you the latest advancements in the field of diagnostic imaging, through cutting-edge technology and/or artificial intelligence. We invested €5.4 billion into crucial research and development in 2021 alone.
We remain committed to advancing scientific progress, as demonstrated by our extensive record of research publications and clinical studies.
Gadovist® has demonstrated efficacy and a well established benefit-risk profile in more than 4000 studies, with several significant studies including DENSE, GadaCAD, LEADER-75, and GEMMA.
Reliable Supply
A Trusted Global Network
Bayer’s global supply network aims to provide you with a reliable supply of products by maintaining high safety and quality standards in adherence with good manufacturing practice (GMP) guidelines. We believe that reliable patient care depends on having a steady supply of high-quality contrast agents. That's why we have expanded our capacity to meet growing demands.. and offer
Customized Business Models so you can take advantage of our solutions without added financial pressures or administrative complexity.
Backed by more than 4000 studies, Gadovist® enhances much more than just the quality of images. Learn how Gadovist® in combination with the Bayer portfolio helps you enhance more than the image.
Talk to Our Team
To learn more about Gadovist® or other Bayer
Radiology solutions, visit our contact page.
- Referencesexpand_less
- 1Endrikat J, Gutberlet M, Barkhausen J, et al. Clinical Efficacy of Gadobutrol: Review of Over 25 Years of Use Exceeding 100 Million Administrations. Invest Radiol. 2024;59(5):345-358. doi:10.1097/RLI.0000000000001041
- 2Endrikat J, Gutberlet M, Hoffmann KT, et al. Clinical Safety of Gadobutrol: Review of Over 25 Years of Use Exceeding 100 Million Administrations. Invest Radiol. Published online March 1, 2024. doi:10.1097/RLI.0000000000001072
- 3Bayer. About Us. Accessed 2024. https://www.radiology.bayer.com/about-us
- 4European Society of Radiology (ESR). Impact of artificial intelligence on radiology: a EuroAIM survey among members of the European Society of Radiology. Insights Imaging. 2019;10(1):105.
- 5Bayer. Annual Report 2021. Accessed 2024. https://www.bayer.com/sites/default/files/2022-03/Bayer-Annual-Report-2021.pdf
- 6Bayer. Data on File.
- 7Emaus MJ, et al. MR imaging as an additional screening modality for the detection of breast cancer in women aged 50–75 years with extremely dense breasts: the DENSE trial study design. Radiology. 2015;277(2):527-37.
- 8Arai AE, et al. Gadobutrol-Enhanced Cardiac Magnetic Resonance Imaging for Detection of Coronary Artery Disease. J Am Coll Cardiol. 2020;76(13):1536-1547.
- 9Liu BP, et al. Clinical Efficacy of Reduced-Dose Gadobutrol Versus Standard-Dose Gadoterate for Contrast-Enhanced MRI of the CNS: An International Multicenter Prospective Crossover Trial (LEADER-75). AJR Am J Roentgenol. 2021;217(5):1195-1205.
- 10Sardanelli F, et al. Gadobutrol-Enhanced Magnetic Resonance Imaging of the Breast in the Preoperative Setting: Results of 2 Prospective International Multicenter Phase III Studies. Invest Radiol. 2016;51(7):454-61.
- 11Bayer. Kontrastmittel made in Germany. 2018. PP-GAD-DE-0028.
- 12Bayer. Kontrastmittel made in Germany. Accessed 2024.https://www.radiologie.bayer.de/aktuelles/news/kontrastmittel-made-in-germany